Inhibition of neuronal cyclooxygenase-2 (COX-2) and hence prostaglandin E 2 (PGE 2 ) synthesis by non-steroidal anti-inflammatory drugs has been suggested to protect neuronal cells in a variety of pathophysiological situations including Alzheimer's disease and ischemic stroke. Ascorbic acid (vitamin C) has also been shown to protect cerebral tissue in a variety of experimental conditions, which has been attributed to its antioxidant capacity. In the present study, we show that ascorbic acid dose-dependently inhibited interleukin-1h (IL-1h)-mediated PGE 2 synthesis in the human neuronal cell line, SK-N-SH. Furthermore, in combination with aspirin, ascorbic acid augmented the inhibitory effect of aspirin on PGE 2 synthesis. However, ascorbic acid had no synergistic effect along with other COX inhibitors (SC-58125 and indomethacin). The inhibition of IL-1h-mediated PGE 2 synthesis by ascorbic acid was not due to the inhibition of the expression of COX-2 or microsomal prostaglandin E synthase (mPGES-1). Rather, ascorbic acid dose-dependently (0.1 -100 AM) produced a significant reduction in IL-1h-mediated production of 8-iso-prostaglandin F 2a (8-iso-PGF 2a ), a reliable indicator of free radical formation, suggesting that the effects of ascorbic acid on COX-2-mediated PGE 2 biosynthesis may be the result of the maintenance of the neuronal redox status since COX activity is known to be enhanced by oxidative stress. Our results provide in vitro evidence that the neuroprotective effects of ascorbic acid may depend, at least in part, on its ability to reduce neuronal COX-2 activity and PGE 2 synthesis, owing to its antioxidant properties. Further, these experiments suggest that a combination of aspirin with ascorbic acid constitutes a novel approach to render COX-2 more sensitive to inhibition by aspirin, allowing an anti-inflammatory therapy with lower doses of aspirin, thereby avoiding the side effects of the usually high dose aspirin treatment. D
Introduction
A large body of evidence implicates both brain inflammation and oxidative stress in the pathophysiological mechanisms contributing to the neuronal death seen in different neurological disorders including Alzheimer's disease (AD), Parkinson's disease and stroke (for a recent review, see Andersen, 2004) . Inflammatory processes may contribute to the neurodegenerative process through mechanisms involving the release of proinflammatory cytokines, reactive oxygen species (ROS), nitric oxide (NO) and prostaglandins.
Prostaglandins are produced by the enzymatic action of cyclooxygenase (COX). Two isoforms of COX have been described: COX-1 and COX-2 (Seibert et al., 1997) . COX-1 is expressed constitutively in many organs and contributes to the synthesis of prostanoids involved in normal cellular functions (Seibert et al., 1997) . COX-2 is expressed in
